Document is current
Any future updates will be listed below
-
Authors
Yip, Olivia https://orcid.org/0009-0009-0090-8530
Bounthavong, Mark https://orcid.org/0000-0002-7343-9458
-
Funding
Funding for this research was provided by:
American Foundation for Pharmaceutical Education (Gateway to Research Awards 2022 - 2023)
Skaggs School of Pharmacy and Pharmaceutical Sciences (Summer Research Program 2022)
- License Information
-
More Information
Article History
Accepted: 8 July 2025
First Online: 20 July 2025
Declarations
:
: OY received Gateway to Research Awards from the American Foundation for Pharmaceutical Education (AFPE) between 2022–2023 and research funding from University of California, San Diego from the 2022 Summer Research Program.
: MB has received consulting fees from Merck & Company and research funding from the National Institutes of Health and the University of California San Diego. OY is currently in a fellowship sponsored by AbbVie, Inc and the University of Washington.
: Not applicable.
: Not applicable.
: Not applicable.
: The model and data supporting the findings of this study are provided in the supplementary materials.
: The model and data supporting the findings of this study are provided in the supplementary materials.
: OY and MB conceptualized and design of the study, acquired the data, and interpreted the findings. OY developed the model, performed validation, and was the primary author of the manuscript. MB supervised the project, reviewed the model and edited the manuscript. The authors whose names appear on the submission have contributed sufficiently to the manuscript.
